BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyake K, Ogawa D, Okada M, Hatakeyama T, Tamiya T. Usefulness of positron emission tomographic studies for gliomas. Neurol Med Chir (Tokyo) 2016;56:396-408. [PMID: 27250577 DOI: 10.2176/nmc.ra.2015-0305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruggiero MR, Baroni S, Aime S, Crich SG. Relaxometric investigations addressing the determination of intracellular water lifetime: a novel tumour biomarker of general applicability. Molecular Physics 2019;117:968-74. [DOI: 10.1080/00268976.2018.1527045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhang Q, Gao X, Wei G, Qiu C, Qu H, Zhou X. Prognostic Value of MTV, SUVmax and the T/N Ratio of PET/CT in Patients with Glioma: A Systematic Review and Meta-Analysis. J Cancer 2019;10:1707-16. [PMID: 31205526 DOI: 10.7150/jca.28605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
3 Rani N, Singh B, Kumar N, Singh P, Hazari PP, Jaswal A, Gupta SK, Chhabra R, Radotra BD, Mishra AK. The diagnostic performance of 99mTc-methionine single-photon emission tomography in grading glioma preoperatively: a comparison with histopathology and Ki-67 indices. Nucl Med Commun 2020;41:848-57. [PMID: 32796472 DOI: 10.1097/MNM.0000000000001230] [Reference Citation Analysis]
4 Mansoor NM, Thust S, Militano V, Fraioli F. PET imaging in glioma: techniques and current evidence. Nucl Med Commun 2018;39:1064-80. [PMID: 30303860 DOI: 10.1097/MNM.0000000000000914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nakano T, Tamura K, Tanaka Y, Inaji M, Hayashi S, Kobayashi D, Nariai T, Toyohara J, Ishii K, Maehara T. Usefulness of 11C-Methionine Positron Emission Tomography for Monitoring of Treatment Response and Recurrence in a Glioblastoma Patient on Bevacizumab Therapy: A Case Report. Case Rep Oncol 2018;11:442-9. [PMID: 30057540 DOI: 10.1159/000490457] [Reference Citation Analysis]
6 Miyake K, Suzuki K, Ogawa T, Ogawa D, Hatakeyama T, Shinomiya A, Kudomi N, Yamamoto Y, Nishiyama Y, Tamiya T. Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria. Neurooncol Adv 2021;3:vdaa172. [PMID: 33681765 DOI: 10.1093/noajnl/vdaa172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]